Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1976
DELISTED
Epizyme, Inc
EPZM
| $6.93M | ﹤0.01% |
552,089
+114,240
| +26% | +$1.66M |
|
1977
Granite Construction
GVA
$5.56B
| $6.92M | ﹤0.01% |
109,120
+65,405
| +150% | +$4.08M |
|
1978
Sensient Technologies
SXT
$5.68B
| $6.92M | ﹤0.01% |
94,548
+31,375
| +50% | +$2.39M |
|
|
ENLC
1979
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $6.92M | ﹤0.01% |
392,962
-217,975
| -36% | -$3.58M |
|
1980
AMC Global Media
AMCX
$510M
| $6.91M | ﹤0.01% |
+127,762
| New | +$6.82M |
|
1981
AtriCure
ATRC
$2.25B
| $6.91M | ﹤0.01% |
378,639
+44,074
| +13% | +$873K |
|
1982
PUT
Cardinal Health
CAH
$54.7B
| $6.9M | ﹤0.01% |
112,600
+55,600
| +98% | +$3.44M |
|
1983
PUT
Masco
MAS
$14.7B
| $6.9M | ﹤0.01% |
157,000
+102,400
| +188% | +$4.16M |
|
1984
PUT
Targa Resources
TRGP
$59.1B
| $6.87M | ﹤0.01% |
141,900
+26,500
| +23% | +$1.18M |
|
|
NPTN
1985
DELISTED
NEOPHOTONICS CORP
NPTN
| $6.87M | ﹤0.01% |
1,043,580
+645,820
| +162% | +$3.94M |
|
1986
Cal-Maine
CALM
$3.8B
| $6.86M | ﹤0.01% |
+154,349
| New | +$6.88M |
|
1987
Pultegroup
PHM
$24.8B
| $6.86M | ﹤0.01% |
206,288
-889,407
| -81% | -$27.6M |
|
1988
PUT
State Street SPDR S&P Bank ETF
KBE
$1.76B
| $6.85M | ﹤0.01% |
144,700
+79,100
| +121% | +$3.64M |
|
1989
AZZ Inc
AZZ
$4.55B
| $6.84M | ﹤0.01% |
133,915
+17,556
| +15% | +$831K |
|
1990
PUT
Helmerich & Payne
HP
$4.42B
| $6.84M | ﹤0.01% |
105,800
-104,400
| -50% | -$5.85M |
|
|
GWPH
1991
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $6.84M | ﹤0.01% |
51,800
-400
| -0.8% | -$47K |
|
|
WPG
1992
DELISTED
Washington Prime Group Inc.
WPG
| $6.84M | ﹤0.01% |
106,686
+60,347
| +130% | +$4.1M |
|
1993
CALL
Urban Outfitters
URBN
$6.66B
| $6.83M | ﹤0.01% |
194,700
+17,600
| +10% | +$493K |
|
1994
DigitalBridge
DBRG
$2.94B
| $6.82M | ﹤0.01% |
149,325
+81,228
| +119% | +$3.99M |
|
1995
Sempra
SRE
$56.5B
| $6.79M | ﹤0.01% |
126,994
+35,134
| +38% | +$2.04M |
|
1996
PUT
VeriSign
VRSN
$25.7B
| $6.79M | ﹤0.01% |
59,300
+41,300
| +229% | +$4.61M |
|
|
WBC
1997
DELISTED
WABCO HOLDINGS INC.
WBC
| $6.78M | ﹤0.01% |
47,257
-363,992
| -89% | -$53.5M |
|
|
UN
1998
DELISTED
Unilever NV New York Registry Shares
UN
| $6.78M | ﹤0.01% |
120,427
+115,078
| +2,151% | +$6.63M |
|
1999
CALL
Children's Place
PLCE
$54.3M
| $6.77M | ﹤0.01% |
46,600
+20,900
| +81% | +$2.55M |
|
2000
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $6.77M | ﹤0.01% |
166,300
+32,600
| +24% | +$1.34M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.